US equities |
INTC $66.02 ▼-28.29% MU $899.03 ▼-3.77% AMZN $236.75 ▼-2.89% NVDA $206.98 ▼-3.13% SNDK $1,234.80 ▼-7.16% GOOGL $281.56 ▼-0.80% AAPL $344.78 ▼-1.18% AMD $519.61 ▼-8.26%
FinancialContent

Articles published by X4 Pharmaceuticals, Inc.

News headline image
X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
From X4 Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers XFOR